Carl Zeiss Vision announced today a partnership with MDSolarSciences to educate consumers on the importance of full UV protection for both the skin and the eyes. By partnering with a leading, doctor-developed skin care brand, ZEISS hopes to encourage people of all ages to take greater action to ensure their entire faces are fully protected against solar UV rays.
San Diego, USA | 20 March 2019 | ZEISS Vision Care
“We are thrilled to partner with MDSolarSciences in our pursuit of educating consumers about the importance of daily UV protection for both the skin and the eyes,” said Andrew Hyncik, vice president of marketing for ZEISS Vision Care. “Many Americans don’t realize that lenses often don’t protect up to the recommended 400nm threshold for UV, something that sun/skin care companies have been doing for many years, and ZEISS branded lenses now offer.”
Both ZEISS and MDSolarSciences have developed innovative products to help consumers better protect their faces from UV exposure. ZEISS recently launched ZEISS UVProtect Technology that, for the first time, provides full, UV protection up to 400nm in a clear eyeglass lens, the recommended World Health Organization standard. ZEISS UVProtect technology is available in all ZEISS-branded lenses. Meanwhile, the founder of MDSolarScience is a prominent oncologist and dermatologist who created the skincare company which carries
The Skin Cancer Foundation seal of approval, selling clean, safe and nontoxic SPF products that are lab tested for every skin type.
“I realized early in my career that prevention is paramount,” said Robert Friedman, MD, MSc (Med), and founder of MDSolarSciences. “This partnership with ZEISS is an extension of our mission. Together with our joint message we can educate people to take the steps necessary to protect their entire face - skin and eyes – from solar UV radiation.”
According to the Skin Cancer Foundation, clouds block as little as 20 percent of UV rays — so even on an overcast day, when many people may not think to apply sunscreen or protect their eyes, they are still absorbing up to 80 percent of the sun’s UV rays. The daily use of SPF 30+ sunscreen and clear eyeglass lenses with full UV blocking properties can help bridge this gap.
MDSolarSciences was developed by founders Robert J. Friedman, M.D., a leading dermatological oncologist and Clinical Professor at the NYU School of Medicine and Bruce Deitchman, M.D., a leading New York dermatologist, and Clinical Associate Professor at the NYU School of Medicine. Based in Stamford Connecticut, its products are sold in more than 800 physician offices, medical spas, resorts, independent pharmacies and specialty retailers. MDSolarScience products are also available online at www.mdsolarsciences.com.
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 5.8 billion euros in its four segments Industrial Quality & Research, Medical Technology, Consumer Markets and Semiconductor Manufacturing Technology (status: 30 September 2018).
For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.
With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future far beyond the optics and optoelectronics industries. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership.
With around 30,000 employees, ZEISS is represented in nearly 50 countries, with approximately 60 of its own sales and service companies and 30 manufacturing and development centers around the globe. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.
For more information, please visit www.zeiss.com
ZEISS Vision Care
ZEISS Vision Care is one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments. The area is part of the Consumer Markets segment and develops and produces offerings for the entire eyeglass value chain that are distributed globally under the ZEISS brand.